Ironwood Pharmaceuticals
IRWD
IRWD
167 hedge funds and large institutions have $2.78B invested in Ironwood Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 63 increasing their positions, 51 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 162 → 167 (+5)
0.03% more ownership
Funds ownership: 131.42% → 131.45% (+0.03%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
167
Holding in Top 10
3
Calls
$4.66M
Puts
$3.6M
Top Buyers
| 1 | +$150M | |
| 2 | +$42.6M | |
| 3 | +$21.2M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$16M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$11.7M |
Top Sellers
| 1 | -$47.7M | |
| 2 | -$28M | |
| 3 | -$14.8M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$14.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.6M |